Alterity Therapeutics Limited
ATHE · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,148 | -$19,123 | -$13,807 | -$12,847 |
| Dep. & Amort. | $140 | $148 | $102 | $54 |
| Deferred Tax | $0 | $0 | $2,991 | -$1,058 |
| Stock-Based Comp. | $980 | $882 | $967 | $1,506 |
| Change in WC | -$614 | $5,749 | -$3,940 | -$448 |
| Other Non-Cash | $191 | -$261 | -$6,349 | $456 |
| Operating Cash Flow | -$11,451 | -$12,606 | -$20,036 | -$12,337 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$6 | -$7 | -$89 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7,500 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$29 | $0 |
| Investing Cash Flow | -$7,500 | -$6 | -$36 | -$89 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$127 | -$10 | -$60 | -$35 |
| Stock Issued | $42,571 | $10,145 | $317 | $17,176 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,774 | -$918 | -$132 | -$837 |
| Financing Cash Flow | $39,669 | $9,216 | $124 | $16,305 |
| Forex Effect | -$198 | $260 | $915 | $2,813 |
| Net Chg. in Cash | $20,520 | -$3,135 | -$19,033 | $6,691 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,639 | $15,774 | $34,807 | $28,116 |
| End Cash | $33,159 | $12,639 | $15,774 | $34,807 |
| Free Cash Flow | -$11,451 | -$12,612 | -$20,043 | -$12,426 |